Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
PurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Material...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/full |
_version_ | 1797860868478730240 |
---|---|
author | Tae Il Noh Ji Sung Shim Seok Ho Kang Jun Cheon Sung Gu Kang |
author_facet | Tae Il Noh Ji Sung Shim Seok Ho Kang Jun Cheon Sung Gu Kang |
author_sort | Tae Il Noh |
collection | DOAJ |
description | PurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Materials and methodsThis study included 1077 men who underwent transperineal bi-parametric (bp) magnetic resonance imaging (MRI)–ultrasound (US) fusion TB+SB (bpMRI-US FTSB) between April 2019 and March 2022. To compare the performance of each modality (TB, SB, and combined TB+SB) with the RP specimen (as the standard) for detecting PCa and clinically significant PCa (csPCa), receiver operating characteristic (ROC) curves were plotted.ResultsPCa was detected in 581 of 1077 men (53.9%) using bpMRI-US FTSB. CsPCa was detected in 383 of 1077 men (35.6%), 17 of 285 (6.0%) with PI-RADS 0 to 2, 35 of 277 (12.6%) with PI-RADS 3, 134 of 274 (48.9%) with PI-RADS 4, and 197 of 241 (81.7%) with PI-RADS 5, respectively. The additional diagnostic value of TB vs. SB compared to combined TB+SB for diagnosing csPCa were 4.3% vs. 3.2% (p=0.844), 20.4% vs 5.1% (p<0.001), and 20.3% vs. 0.7% (p<0.001) with PI-RADS 3, 4, and 5, respectively. TB alone showed no significant difference in diagnostic performance for csPCa with combined TB+SB based on RP specimens in patients with PI-RADS 5 (p=0.732).ConclusionA need for addition of SB to TB in patients with PI-RADS 3 and 4 lesions, however, TB alone may be performed without affecting the management of patients with PI-RADS 5. |
first_indexed | 2024-04-09T21:52:55Z |
format | Article |
id | doaj.art-34652d3d31604059b692ca622a683bd1 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-09T21:52:55Z |
publishDate | 2023-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-34652d3d31604059b692ca622a683bd12023-03-24T11:00:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11420221142022Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imagingTae Il NohJi Sung ShimSeok Ho KangJun CheonSung Gu KangPurposeTo compare the diagnostic performance of transperineal targeted biopsy (TB) or systematic biopsy (SB) alone based on combined TB+SB and radical prostatectomy (RP) specimen for detecting prostate cancer (PCa) according to the prostate imaging reporting and data system (PI-RADS) score. Materials and methodsThis study included 1077 men who underwent transperineal bi-parametric (bp) magnetic resonance imaging (MRI)–ultrasound (US) fusion TB+SB (bpMRI-US FTSB) between April 2019 and March 2022. To compare the performance of each modality (TB, SB, and combined TB+SB) with the RP specimen (as the standard) for detecting PCa and clinically significant PCa (csPCa), receiver operating characteristic (ROC) curves were plotted.ResultsPCa was detected in 581 of 1077 men (53.9%) using bpMRI-US FTSB. CsPCa was detected in 383 of 1077 men (35.6%), 17 of 285 (6.0%) with PI-RADS 0 to 2, 35 of 277 (12.6%) with PI-RADS 3, 134 of 274 (48.9%) with PI-RADS 4, and 197 of 241 (81.7%) with PI-RADS 5, respectively. The additional diagnostic value of TB vs. SB compared to combined TB+SB for diagnosing csPCa were 4.3% vs. 3.2% (p=0.844), 20.4% vs 5.1% (p<0.001), and 20.3% vs. 0.7% (p<0.001) with PI-RADS 3, 4, and 5, respectively. TB alone showed no significant difference in diagnostic performance for csPCa with combined TB+SB based on RP specimens in patients with PI-RADS 5 (p=0.732).ConclusionA need for addition of SB to TB in patients with PI-RADS 3 and 4 lesions, however, TB alone may be performed without affecting the management of patients with PI-RADS 5.https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/fullmagnetic resonance imagingtransperineal biopsyprostate cancerPI-RADStarget biopsy |
spellingShingle | Tae Il Noh Ji Sung Shim Seok Ho Kang Jun Cheon Sung Gu Kang Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging Frontiers in Oncology magnetic resonance imaging transperineal biopsy prostate cancer PI-RADS target biopsy |
title | Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging |
title_full | Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging |
title_fullStr | Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging |
title_full_unstemmed | Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging |
title_short | Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging |
title_sort | diagnostic performance of transperineal prostate targeted biopsy alone according to the pi rads score based on bi parametric magnetic resonance imaging |
topic | magnetic resonance imaging transperineal biopsy prostate cancer PI-RADS target biopsy |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1142022/full |
work_keys_str_mv | AT taeilnoh diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging AT jisungshim diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging AT seokhokang diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging AT juncheon diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging AT sunggukang diagnosticperformanceoftransperinealprostatetargetedbiopsyaloneaccordingtothepiradsscorebasedonbiparametricmagneticresonanceimaging |